Fatty liver disease, has become a significant health concern globally, affecting millions. This condition ranges from simple fat accumulation in the liver to more severe forms like non-alcoholic steatohepatitis (NASH), which can lead to liver fibrosis, cirrhosis, and even liver cancer. Emerging research suggests a connection between gut health and liver health—especially in the context of a “leaky gut.”
Understanding the Leaky Gut and Its Role in Fatty Liver
The term “leaky gut” refers to increased intestinal permeability, a condition in which the gut’s tight junctions between cells become compromised. This can let bacterial products such as lipopolysaccharides (LPS) pass into the bloodstream. Once these substances reach the liver through the portal vein, they can trigger inflammation and contribute to the progression of fatty liver disease.
Scientific Evidence: In animal studies, a high-fat diet (HFD) reliably produces both gut dysbiosis (an imbalance in the gut microbiota) and a leakier gut. In people, a review of 14 studies found that those with metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD) tend to have higher intestinal permeability, linked to how much fat is in the liver but not to the degree of inflammation or fibrosis. A leaky gut can let bacterial endotoxins like LPS enter the bloodstream and activate inflammatory pathways in the liver, particularly the TLR4/NF-κB pathway; in experiments this cascade promotes fat accumulation, oxidative stress and liver cell damage. Whether a leaky gut is a cause or a consequence of fatty liver in people is still unclear.
In one study in mice, ginger essential oil (GEO) eased NASH while improving gut health and reducing intestinal permeability, which limited the passage of LPS to the liver. This supports the idea that gut integrity helps protect the liver from inflammatory damage.
Nutrients Studied in Fatty Liver
Several nutrients have been studied for their role in liver fat metabolism and, in animal models, the gut barrier. Four of them are choline, inositol, methionine and taurine.
1. Choline
Choline is an essential nutrient for liver health. Choline is a key component of phosphatidylcholine, a phospholipid crucial for fat metabolism and the transport of lipids out of the liver. When choline levels are insufficient, fat tends to accumulate in the liver, contributing to NAFLD. In patients on long-term intravenous feeding who lacked choline, giving it back reversed the liver fat; trials of extra choline in people with ordinary fatty liver are lacking. Choline contributes to normal lipid metabolism and to the maintenance of normal liver function; if you want to know why we built LiverGuard around it, the product page explains the reasoning.
2. Inositol
Inositol, a compound often grouped with B vitamins, plays a significant role in fat metabolism and insulin signaling. It helps regulate lipid levels in the liver by influencing pathways involved in fat transport and storage. A systematic review found that inositol supplementation reduced liver fat in animal models; the one human trial it identified, using a related compound (pinitol), also lowered liver fat. Evidence in people is therefore still thin.
3. Methionine
Methionine is an essential amino acid involved in various metabolic processes, including the synthesis of S-adenosylmethionine (SAMe), a compound crucial for liver health. SAMe plays a critical role in detoxification, and it helps protect liver cells from damage by oxidative stress. In rodents, a diet lacking methionine and choline causes fatty liver with inflammation; that extra methionine reduces liver fat or aids repair in people has not been shown.
4. Taurine
Taurine is a sulfur-containing amino acid with antioxidant and anti-inflammatory properties in laboratory studies. In animal models of fatty liver it reduced oxidative stress and fat build-up in the liver. It is also used to form bile salts, which aid fat digestion. In animal studies taurine has also tightened the gut barrier; this has not been tested in people.
The Gut-Liver Axis: A Two-Way Street
The relationship between the gut and liver is often described as the “gut-liver axis,” a two-way communication system. A diverse and balanced microbiota is associated with a tighter gut barrier, which may help shield the liver from inflammatory damage. Conversely, a compromised gut barrier is thought to feed liver inflammation; whether it causes NAFLD is still being studied.
Prebiotics and probiotics are being tested as ways to support the gut barrier, but the 2024 European guideline does not list them among recommended treatments for MASLD. For choline, inositol, methionine and taurine, the evidence on the gut barrier comes from animal studies. What reliably reduces liver fat is weight loss: 5 percent or more of body weight, according to the same guideline.
Conclusion
Leaky gut is an emerging player in the development and progression of fatty liver disease. The literature suggests that gut health matters for the liver, though much of the evidence comes from animal studies. Choline, inositol, methionine and taurine are part of that research, but none has been shown to reverse fatty liver in people. A well-rounded diet, regular activity and weight loss where needed remain the approach with the strongest evidence.
Looking after the gut is one part of looking after the liver, alongside the factors with the strongest evidence: body weight, diet quality and physical activity.
Resources
- Panyod, S., Wu, W.K., Hsieh, Y.C., et al. Ginger essential oil prevents NASH progression by blocking the NLRP3 inflammasome and remodeling the gut microbiota-LPS-TLR4 pathway in mice. Nutrition and Diabetes, 2024.
DOI: 10.1038/s41387-024-00306-1 - Corbin, K.D., Zeisel, S.H. Choline metabolism provides novel insights into non-alcoholic fatty liver disease and its progression. Current Opinion in Gastroenterology, 2012.
DOI: 10.1097/MOG.0b013e32834e7b4b - Pani, A., Giossi, R., Menichelli, D., et al. (2020). Inositol and non-alcoholic fatty liver disease: a systematic review on deficiencies and supplementation. Nutrients, 12(11), 3379. DOI: 10.3390/nu12113379
- Caballero, F., Fernández, A., Matías, N., et al. (2010). Specific contribution of methionine and choline in nutritional nonalcoholic steatohepatitis: impact on mitochondrial S-adenosyl-L-methionine and glutathione. Journal of Biological Chemistry, 285(24), 18528-18536. DOI: 10.1074/jbc.M109.099333
- Murakami, S., Ono, A., Kawasaki, A., et al. (2018). Taurine attenuates the development of hepatic steatosis through the inhibition of oxidative stress in a model of nonalcoholic fatty liver disease in vivo and in vitro. Amino Acids, 50(9), 1279-1288. DOI: 10.1007/s00726-018-2605-8
- De Munck, T. J. I., Xu, P., Verwijs, H. J. A., et al. (2020). Intestinal permeability in human nonalcoholic fatty liver disease: A systematic review and meta-analysis. Liver International, 40(12), 2906-2916. DOI: 10.1111/liv.14696
- Buchman, A. L., Dubin, M. D., et al. (1995). Choline deficiency: a cause of hepatic steatosis during parenteral nutrition that can be reversed with intravenous choline supplementation. Hepatology, 22(5), 1399-1403. DOI: 10.1016/0270-9139(95)90143-4
- Wen, C., Guo, Q., Wang, W., et al. (2020). Taurine alleviates intestinal injury by mediating tight junction barriers in diquat-challenged piglet models. Frontiers in Physiology, 11, 449. DOI: 10.3389/fphys.2020.00449
- European Association for the Study of the Liver, European Association for the Study of Diabetes, European Association for the Study of Obesity. (2024). EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). Journal of Hepatology, 81(3), 492-542. DOI: 10.1016/j.jhep.2024.04.031
